Stock Scorecard



Stock Summary for Viatris Inc (VTRS) - $10.62 as of 11/28/2025 3:05:30 PM EST

Total Score

7 out of 30

Safety Score

48 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for VTRS

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for VTRS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for VTRS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for VTRS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for VTRS (48 out of 100)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 5
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 5
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for VTRS

Net income before discontinued operations of Viatris, Inc. – SIX:VTRS 11/30/2025 7:07:00 AM
Cash per share of Viatris, Inc. – SIX:VTRS.USD 11/30/2025 7:07:00 AM
Merz fails with PI request in first ever SPC case against Viatris 11/25/2025 12:00:00 AM
Viatris Inc. stock rises Monday, outperforms market 11/24/2025 10:17:00 PM
Viatris to Participate in Upcoming Investor Conferences 11/24/2025 8:00:00 AM
Viatris (Nasdaq: VTRS) schedules Dec. 2–3 fireside chats at Piper Sandler and Evercore 11/24/2025 8:00:00 AM
Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know 11/23/2025 8:36:00 PM
Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know 11/21/2025 6:55:00 PM
Medical Morphine Market Deep Research Report with Forecast 11/21/2025 11:38:00 AM
(VTRS) Movement Within Algorithmic Entry Frameworks 11/20/2025 4:36:00 PM

Financial Details for VTRS

Company Overview

Ticker VTRS
Company Name Viatris Inc
Country USA
Description Viatris Inc. (VTRS) is a leading global healthcare company based in Canonsburg, Pennsylvania, resulting from the strategic merger of Mylan and Upjohn, a division of Pfizer. With a diverse portfolio that includes generic, branded, and over-the-counter medications, Viatris is committed to increasing access to high-quality healthcare in over 165 countries. The company focuses on addressing a wide range of health challenges and improving patient outcomes through innovation and an extensive distribution network. As it adapts to the evolving healthcare landscape, Viatris is dedicated to providing cost-effective solutions that enhance healthcare systems and ensure long-term sustainability.
Sector Name HEALTHCARE
Industry Name DRUG MANUFACTURERS - SPECIALTY & GENERIC
Most Recent Quarter 9/30/2025
Next Earnings Date N/A

Stock Price History

Last Day Price 10.62
Price 4 Years Ago 11.32
Last Day Price Updated 11/28/2025 3:05:30 PM EST
Last Day Volume 2,713,247
Average Daily Volume 8,809,256
52-Week High 12.61
52-Week Low 6.60
Last Price to 52 Week Low 60.91%

Valuation Measures

Trailing PE N/A
Industry PE 85.51
Sector PE 89.93
5-Year Average PE 3.86
Free Cash Flow Ratio 12.21
Industry Free Cash Flow Ratio 12.46
Sector Free Cash Flow Ratio 29.09
Current Ratio Most Recent Quarter 1.26
Total Cash Per Share 0.87
Book Value Per Share Most Recent Quarter 13.13
Price to Book Ratio 0.81
Industry Price to Book Ratio 10.31
Sector Price to Book Ratio 33.13
Price to Sales Ratio Twelve Trailing Months 0.87
Industry Price to Sales Ratio Twelve Trailing Months 2.71
Sector Price to Sales Ratio Twelve Trailing Months 16.04
Analyst Buy Ratings 3
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 1,151,770,000
Market Capitalization 12,231,797,400
Institutional Ownership 86.84%

Dividends

Ex-Dividend Date 11/24/2025
Previous Dividend Amount 0.1200
Current Dividend Amount 0.1200
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.48
Trailing Annual Dividend Yield 4.49%
Forward Annual Dividend Rate 0.48
Forward Annual Dividend Yield 4.49%
5-Year Dividend Payments Count 19
3-Year Average Dividend Yield 4.45%
5-Year Average Dividend Yield 4.62%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 18.92%
All-Time Dividend Growth Rate Percentage 15.79%
Dividend Payout Ratio -15.34%

Income Statement

Quarterly Earnings Growth YOY -70.60%
Annual Earnings Growth -1,259.41%
Reported EPS 12 Trailing Months -3.13
Reported EPS Past Year 1.79
Reported EPS Prior Year 2.65
Net Income Twelve Trailing Months -3,691,299,999
Net Income Past Year -634,200,000
Net Income Prior Year 54,700,000
Quarterly Revenue Growth YOY 0.20%
5-Year Revenue Growth 5.09%
Operating Margin Twelve Trailing Months 10.80%

Balance Sheet

Total Cash Most Recent Quarter 1,003,500,000
Total Cash Past Year 734,800,000
Total Cash Prior Year 991,900,000
Net Cash Position Most Recent Quarter -11,484,100,000
Net Cash Position Past Year -13,304,100,000
Long Term Debt Past Year 14,038,900,000
Long Term Debt Prior Year 16,188,100,000
Total Debt Most Recent Quarter 12,487,600,000
Equity to Debt Ratio Past Year 0.57
Equity to Debt Ratio Most Recent Quarter 0.55
Total Stockholder Equity Past Year 18,635,500,000
Total Stockholder Equity Prior Year 20,467,400,000
Total Stockholder Equity Most Recent Quarter 15,217,600,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 1,599,200,000
Free Cash Flow Per Share Twelve Trailing Months 1.39
Free Cash Flow Past Year 1,976,900,000
Free Cash Flow Prior Year 2,325,100,000

Options

Put/Call Ratio 0.25
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.11
MACD Signal 0.12
20-Day Bollinger Lower Band 8.77
20-Day Bollinger Middle Band 9.93
20-Day Bollinger Upper Band 11.09
Beta 0.84
RSI 56.15
50-Day SMA 9.56
150-Day SMA 9.82
200-Day SMA 9.69

System

Modified 11/29/2025 10:51:20 AM EST